Suppr超能文献

结核病(TB)诊断工具包:印度多中心研究(2006-2008 年)。评价 QuantiFERON-TB gold in tube 用于结核病诊断。

A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of QuantiFERON-TB gold in tube for TB diagnosis.

机构信息

Service de Microbiologie, Hôpital Saint Louis, Assistance Publique- Hôpitaux de Paris, Paris VII Denis Diderot University, Paris, France.

出版信息

PLoS One. 2013 Sep 6;8(9):e73579. doi: 10.1371/journal.pone.0073579. eCollection 2013.

Abstract

BACKGROUND

The aim of this multicentric prospective study in India was to assess the performance of the QuantiFERON TB-Gold in tube (QFT-GIT), Tuberculin Skin Test (TST) and microbiological results as additional tools for diagnosing active tuberculosis (TB) and latent infection (LTBI) according to Human Immunodeficiency Virus (HIV) status.

METHODS

Individuals with and without active TB and HIV infection were enrolled between 2006-2008. QFT-GIT and TST results were analyzed per se and in combination with microbiological data.

RESULTS

Among the 276 individuals (96 active pulmonary TB and 180 no active TB) tested by QFT-GIT, 18 indeterminate results (6.5%) were found, more significantly numerous in the HIV-infected (15/92; 16.3%) than the HIV-uninfected (3/184; 1.6%)(p<0.0001). QFT-GIT sensitivity for active TB was 82.3% and 92.9% respectively after including or excluding indeterminate results. Clinical sensitivity was significantly lower in the HIV-infected (68.4%) than the HIV-uninfected (91.4%) patients (p = 0.0059). LTBI was detected in 49.3% of subjects without active TB but varied according to TB exposure. When the TST and QFT-GIT were concomitantly performed, the respective sensitivity for active TB diagnosis was 95.0% and 85.0% in the HIV-uninfected (p = 0.60), and 66.7% and 51.5% in the HIV-infected patients (p = 0.32). QFT-GIT and TST respective specificity for active TB in the HIV-uninfected was 25.0% and 57.1% (p = 0.028), and 64.8% and 83.3% in the HIV-infected (p = 0.047). In those with active TB, QFT-GIT results were not associated with microbiological parameters (smear grade, liquid culture status, time-to-positivity of culture) or clinical suspicion of active TB score (provided by the clinicians at enrollment). Combining microbiological tests with both immunological tests significantly increased sensitivity for active TB diagnosis (p = 0.0002), especially in the HIV-infected individuals (p = 0.0016).

CONCLUSION

QFT-GIT and TST have similar diagnostic value for active TB diagnosis. In HIV-infected patients, combining microbiological tests with both immunological tests significantly increases the sensitivity for active TB diagnosis.

摘要

背景

本项在印度进行的多中心前瞻性研究旨在评估结核菌素皮下试验(TST)、QuantiFERON TB-Gold in tube(QFT-GIT)和微生物学结果在人类免疫缺陷病毒(HIV)感染患者中的表现,这些结果被用作辅助诊断活动性结核病(TB)和潜伏性结核感染(LTBI)的工具。

方法

2006 年至 2008 年间,纳入了活动性 TB 和 HIV 感染者及无活动性 TB 和 HIV 感染者。QFT-GIT 和 TST 结果分别进行分析,也与微生物学数据联合分析。

结果

在 276 名接受 QFT-GIT 检测的个体(96 名活动性肺结核和 180 名无活动性肺结核)中,发现 18 例不确定结果(6.5%),HIV 感染者中的不确定结果数量显著更多(15/92;16.3%),而 HIV 未感染者中则较少(3/184;1.6%)(p<0.0001)。纳入或排除不确定结果后,QFT-GIT 对活动性 TB 的敏感度分别为 82.3%和 92.9%。HIV 感染者中的临床敏感度显著低于 HIV 未感染者(68.4%比 91.4%)(p=0.0059)。49.3%无活动性 TB 的个体存在 LTBI,但 LTBI 检出率因 TB 暴露而异。当同时进行 TST 和 QFT-GIT 检测时,HIV 未感染者中 TST 和 QFT-GIT 对活动性 TB 的诊断敏感度分别为 95.0%和 85.0%(p=0.60),HIV 感染者中分别为 66.7%和 51.5%(p=0.32)。HIV 未感染者中,TST 和 QFT-GIT 对活动性 TB 的特异性分别为 25.0%和 57.1%(p=0.028),HIV 感染者中则分别为 64.8%和 83.3%(p=0.047)。在活动性 TB 患者中,QFT-GIT 结果与微生物学参数(涂片等级、液体培养状态、培养阳性时间)或活动性 TB 临床可疑评分(由入组时的临床医生提供)无关。将微生物学检测与两种免疫学检测相结合,可显著提高对活动性 TB 的诊断敏感度(p=0.0002),特别是在 HIV 感染者中(p=0.0016)。

结论

QFT-GIT 和 TST 对活动性 TB 的诊断价值相当。在 HIV 感染者中,将微生物学检测与两种免疫学检测相结合,可显著提高对活动性 TB 的诊断敏感度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/3765270/659216d62ad5/pone.0073579.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验